(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(185, '<div id="spr0_aefa75f"><div id="spr1_aefa75f" class="kern slide"><img id="img1_aefa75f" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aefa75f" class="kern slide"><div id="spr3_aefa75f" style="left:-0px;top:78.638px;"><div style="width:0px;"><span id="txt0_aefa75f" data-width="548.203125" style="left:86.855px;top:0.564px;">Genomic index for sensitivity to endocrine therapy (SET)</span></div></div><div id="spr4_aefa75f" style="left:36.183px;top:206.183px;"><img id="img0_aefa75f" src="data/img268.png" width="399" height="311.25" alt="" style="left:-0.038px;top:-0.128px;"/></div><div id="spr5_aefa75f" style="left:1.864px;top:130.763px;"><div style="width:0px;"><span id="txt1_aefa75f" data-width="478.515625" style="left:119.341px;top:1.07px;">Expression of 165 ER-related genes instead of the single ER</span></div></div><div id="spr6_aefa75f" style="left:239.047px;top:180.38px;"><div style="width:0px;"><span id="txt2_aefa75f" class="relpos" data-width="282.273438" style="left:7.2px;top:1.576px;">Relapse-free survival in tamoxifen-treated (</span><span id="txt3_aefa75f" class="relpos" data-width="40.406250" style="left:7.195px;top:1.576px;">ER+ve</span><span id="txt4_aefa75f" class="relpos" data-width="63.695313" style="left:7.19px;top:1.576px;">) tumours</span></div></div><div id="spr7_aefa75f" style="left:264.946px;top:518.189px;"><div style="width:0px;"><span id="txt5_aefa75f" data-width="208.892578" style="left:7.2px;top:2.082px;">Symmans, 2010, J Clin Oncol 28:4111-4119</span></div></div><div id="spr8_aefa75f" style="left:417.182px;top:248.172px;"><div style="width:0px;"><span id="txt6_aefa75f" data-width="224.521484" style="left:39.136px;top:1.07px;">Low activity of ER-signalling</span></div><div style="width:0px;"><span id="txt7_aefa75f" data-width="225.937500" style="left:38.461px;top:25.07px;">despite the presence of ER?</span></div></div><div id="svg19_aefa75f" style="left:318.477px;top:262.752px;"><svg width="370" height="121" viewBox="-120.262 -39.962 370 121"><g fill="none"><g transform="translate(1.125,1.125)"><g><g fill="#ff0000" stroke="none" transform="translate(-0.012386,33.375137)"><path stroke="#ff0000" stroke-width="2.25" stroke-linecap="butt" transform="translate(0.012386,-33.375137)" d="M8.058,38.659 L4.465,38.699"/><path transform="matrix(-0.999939,0.011011,-0.011011,-0.999939,8.070238,5.284126)" d="M-0.365,4.764 Q-0.604,4.88 -0.737,4.898 Q-0.869,4.916 -1.131,4.867 Q-1.382,4.78 -1.488,4.699 Q-1.594,4.617 -1.745,4.398 Q-1.861,4.159 -1.879,4.026 Q-1.896,3.894 -1.848,3.632 Q-1.761,3.381 -1.679,3.275 L-1.598,3.169 L-1.379,3.018 L3.593,0 L-1.379,-3.018 Q-1.598,-3.169 -1.679,-3.275 Q-1.761,-3.381 -1.848,-3.632 Q-1.896,-3.894 -1.879,-4.026 Q-1.861,-4.159 -1.745,-4.398 Q-1.594,-4.617 -1.488,-4.699 Q-1.382,-4.78 -1.131,-4.867 Q-0.869,-4.916 -0.737,-4.898 L-0.604,-4.88 L-0.365,-4.764 L8.058,0"/></g><path stroke="#ff0000" stroke-width="2.25" stroke-linecap="butt" d="M119.137,-0 A119.137,38.748 0 0,1 8.058,38.659"/></g></g></g></svg></div><div id="spr9_aefa75f" style="left:-1.054px;top:7.784px;"><div style="width:0px;"><span id="txt8_aefa75f" data-width="418.427734" style="left:38.411px;top:0.058px;">Biomarkers development: example 1</span></div></div></div></div>');})();